Valuation: Optimax Holdings

Market Cap 285M 70.06M 61.25M 56.29M 52.47M 99.51M 6.67B 101M 676M 263M 3.28B 263M 257M 11.3B P/E 2026 *
18.4x
P/E 2027 * 16.3x
Enterprise Value 282M 69.3M 60.58M 55.68M 51.9M 98.43M 6.6B 99.92M 668M 260M 3.24B 260M 255M 11.18B EV / Sales 2026 *
1.86x
EV / Sales 2027 * 1.73x
Free-Float
23.9%
Yield 2026 *
3.01%
Yield 2027 * 3.5%
05-25 Maybank Research Downgrades Optimax Holdings to Hold from Buy; Price Target is MYR0.58 MT
05-22 Optimax Holdings Berhad Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
03-03 Optimax to Start Offering ENT Services Following Malaysian Health Ministry's Nod MT
03-02 Optimax Holdings Berhad Receives Approval from Ministry of Health to Offer Otorhinolaryngology (Ear, Nose and Throat) Services CI
02-27 Optimax Holdings Berhad Announces Second Interim Single-Tier Dividend on Ordinary Share, Payable 30 March 2026 CI
02-26 Optimax Holdings Berhad Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 CI
11-26 Optimax Holdings Berhad Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
11-26 Optimax Holdings Berhad Announces Interim Single-Tier Dividend for the Year Ended 31 December 2025, Payable on 26 December 2025 CI
08/10/25 Hong Leong Investment Bank Starts Optimax Holdings at Buy with 0.96 Ringgit Price Target MT
27/08/25 Optimax Holdings Berhad Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
28/05/25 Optimax Holdings Berhad Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
27/02/25 Optimax Holdings Berhad Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 CI
27/02/25 Optimax Holdings Berhad Announces Interim Single-Tier Dividend for the Year Ended 31 December 2024, Payable on 28 March 2025 CI
1 day-0.94%
1 week+0.96%
1 month-0.94%
3 months+0.96%
6 months-8.70%
Current year-8.70%
1 week 0.52
Extreme 0.52
0.54
1 month 0.52
Extreme 0.52
0.54
Current year 0.5
Extreme 0.505
0.64
1 year 0.5
Extreme 0.5
0.72
3 years 0.46
Extreme 0.46
0.74
5 years 0.46
Extreme 0.46
0.84
10 years 0.3
Extreme 0.305
0.94
Manager TitleAgeSince
Chief Executive Officer 37 01/12/2019
Director of Finance/CFO 38 01/09/2018
Chief Operating Officer 37 01/01/2024
Director TitleAgeSince
Director/Board Member 81 01/12/2021
Chairman 65 01/12/2021
Director/Board Member 70 09/08/2018
Date Insider Type Main position Quantity % Market Cap.
06-03Buy

Chairman

97,000 0.0179%
05-29Buy

Chairman

3,000 0.0006%
18/04/25
Sena Healthcare Services Sdn. Bhd.
BuyCompany 674,000 0.1241%
Change 5-day change 1-year change 3-year change Capi.($)
-0.94%+0.96%+3.96%-27.59% 70.58M
-0.09%+0.06%+57.24%+51.48% 134B
+4.39%+6.09%+8.59%+35.26% 91.07B
+0.74%+5.78%+0.35%+67.24% 27.15B
-0.14%+4.60%+22.15%+53.47% 23.88B
-0.83%+0.14%-21.29%-26.68% 19.96B
+6.55%+10.75%+18.29%+150.33% 17.55B
+0.62%+3.00%+1.59%+6.78% 15.02B
+3.02%+10.10%+64.78%+133.81% 15.08B
-0.12%+0.51%-14.94%-6.10% 12.65B
Average +1.30%+4.24%+14.07%+43.80% 35.6B
Weighted average by Cap. +1.55%+3.39%+27.18%+48.70%

Financials

2026 *2027 *
Net sales 152M 37.31M 32.61M 29.97M 27.94M 52.99M 3.55B 53.79M 360M 140M 1.75B 140M 137M 6.02B 157M 38.66M 33.79M 31.06M 28.95M 54.9M 3.68B 55.74M 373M 145M 1.81B 145M 142M 6.23B
Net income 15.65M 3.85M 3.36M 3.09M 2.88M 5.46M 366M 5.54M 37.08M 14.42M 180M 14.43M 14.12M 620M 17.6M 4.32M 3.78M 3.47M 3.24M 6.14M 412M 6.23M 41.7M 16.21M 202M 16.23M 15.88M 697M
Net Debt -3.1M -761K -666K -612K -570K -1.08M -72.5M -1.1M -7.34M -2.85M -35.64M -2.86M -2.8M -123M -12.4M -3.05M -2.66M -2.45M -2.28M -4.33M -290M -4.39M -29.38M -11.42M -143M -11.43M -11.19M -491M
Logo Optimax Holdings
Optimax Holdings Berhad is a Malaysia-based investment holding company offering eye specialist services. It has approximately seven satellite clinics/centers, 13 ambulatory care centers, one specialist hospital, and 288 staff/professional doctors. Its geographical segments include North Malaysia, Central Malaysia, South Malaysia, East Malaysia, and Cambodia. Its services are categorized into Refractive Surgery, Treatment of Eye Diseases and Disorders, Consultation and Dispensary Services, Oculoplastic Surgery, Plastic Surgery, and Aesthetic Services. Refractive Surgery includes laser and implant vision correction procedures. Treatment of Eye Diseases and Disorders includes cataract surgery and other medical interventions. Consultation and Dispensary Services cover doctor consultations and medication dispensing. Oculoplastic Surgery provides functional and cosmetic treatments around the eye. Its additional services include Eye Examinations, Sales of Optical Wear, and Laboratory Tests.
Employees
-
Date Price Change Volume
03/07/26 MYR 0.5250 -0.94% 62,500
02/07/26 MYR 0.5300 +0.95% 133,400
01/07/26 MYR 0.5250 0.00% 134,000
30/06/26 MYR 0.5250 0.00% 137,600
29/06/26 MYR 0.5250 +0.96% 115,300
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
0.5250MYR
Average target price
0.6880MYR
Spread / Average Target
+31.05%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 0222 Stock